Madhuri Bajaj
Expertise in
84
conditions

Dr. Madhuri Bajaj

Hematology | Oncology
8940 North Wood Sage Road, 
Peoria, IL 
Accepting New Patients
Offers Telehealth
Expertise in
84
conditions
8940 North Wood Sage Road, 
Peoria, IL 

Overview

Madhuri Bajaj is a Hematologist and an Oncologist practicing medicine in Peoria, Illinois.

Dr. Bajaj is highly rated in 84 conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Paget Disease of the Breast, Pleuropulmonary Blastoma, and Bone Marrow Aspiration.

Dr. Bajaj is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 6 clinical trials. Dr. Bajaj is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in IL

Board Certifications

American Board Of Internal Medicine

Fellowships

Karmanos Cancer Institute - Wayne State University, Oncology/Hematology, 2012

Hospital Affiliations

Osf Saint Elizabeth Mdl Ctr
Carle Health Methodist Hospital
Osf Saint Paul Medical Center
Saint Francis Medical Center
Osf Saint Clare Medical Center

Languages Spoken

English
Spanish

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Illinois CancerCare, P.C.
8940 North Wood Sage Road, Peoria, IL 61615
Other Locations
Illinois CancerCare, P.C.
4391 Venture Drive, Peru, IL 61354
Illinois CancerCare, P.C.
1200 Starfire Drive, Ottawa, IL 61350

Additional Areas of Focus

Dr. Bajaj has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Randomized, Phase II Trial of Intravenous Ascorbic Acid (Vitamin C) as an Adjunct to Pazopanib in the First-Line or Post-Immunotherapy Setting for Metastatic or Unresectable Clear Cell Renal Cell Carcinoma (ccRCC)
Randomized, Phase II Trial of Intravenous Ascorbic Acid (Vitamin C) as an Adjunct to Pazopanib in the First-Line or Post-Immunotherapy Setting for Metastatic or Unresectable Clear Cell Renal Cell Carcinoma (ccRCC)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug
Study Drugs: Ascorbic Acid, Pazopanib Hydrochloride
Study Phase: Phase 2
Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Paclitaxel-Induced Acute Pain Syndrome (P-APS): A Randomized Placebo-Controlled, Double Blind Trial
Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Paclitaxel-Induced Acute Pain Syndrome (P-APS): A Randomized Placebo-Controlled, Double Blind Trial
Enrollment Status: Completed
Publish Date: January 31, 2022
Intervention Type: Other, Drug
Study Phase: Phase 2
A Phase III, Randomized, Open Label Study Evaluating the Safety of Apixaban in Subjects With Cancer Related Venous Thromboembolism
A Phase III, Randomized, Open Label Study Evaluating the Safety of Apixaban in Subjects With Cancer Related Venous Thromboembolism
Enrollment Status: Completed
Publish Date: August 04, 2020
Intervention Type: Drug, Other
Study Phase: Phase 3
An Adaptive, Open-Label, Randomized Phase 2 Study of Abemaciclib as a Monotherapy and in Combination With Other Agents Versus Choice of Standard of Care (Gemcitabine or Capecitabine) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma
An Adaptive, Open-Label, Randomized Phase 2 Study of Abemaciclib as a Monotherapy and in Combination With Other Agents Versus Choice of Standard of Care (Gemcitabine or Capecitabine) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma
Enrollment Status: Completed
Publish Date: November 20, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE)in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer (The METRIC Study)
A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE)in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer (The METRIC Study)
Enrollment Status: Completed
Publish Date: March 08, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

9 Total Publications

Sporadic Mucinous Adenocarcinoma of the Colon in an Adolescent Male: A Case Report and Review of the Literature.
Sporadic Mucinous Adenocarcinoma of the Colon in an Adolescent Male: A Case Report and Review of the Literature.
Journal: Journal of pediatric hematology/oncology
Published: October 22, 2024
Similar Doctors
Expertise in
91
conditions
Dr. Gary R. Macvicar
Hematology | Oncology
Expertise in
91
conditions
Dr. Gary R. Macvicar
Hematology | Oncology
Referral may be required

Illinois CancerCare, P.C.

8940 North Wood Sage Road, 
Peoria, IL 
 (0.1 miles away)
309-243-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gary Macvicar is a Hematologist and an Oncologist practicing medicine in Peoria, Illinois. Dr. Macvicar is highly rated in 91 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Prostate Cancer, Bone Marrow Aspiration, and Orchiectomy. Dr. Macvicar is board certified in American Board Of Internal Medicine. Dr. Macvicar is currently accepting new patients.

Expertise in
111
conditions
Expertise in
111
conditions
Referral may be required

OSF HealthCare Cancer Institute - Medical Oncology

1310 N Missouri Ave, 
Peoria, IL 
 (6.0 miles away)
309-308-3800
Languages Spoken:
English, Mandarin, Zhuang
See accepted insurances
Accepting New Patients
Offers Telehealth

Jun Zhang is an Oncologist practicing medicine in Peoria, Illinois. Dr. Zhang is highly rated in 111 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, Endoscopy, and Angioplasty. Dr. Zhang is board certified in American Board Of Internal Medicine. Dr. Zhang is currently accepting new patients.

Expertise in
105
conditions
Dr. Jijun J. Liu
Hematology | Oncology
Expertise in
105
conditions
Dr. Jijun J. Liu
Hematology | Oncology
Referral may be required

Illinois CancerCare, P.C.

8940 North Wood Sage Road, 
Peoria, IL 
 (0.1 miles away)
309-243-3000
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients
Offers Telehealth

Jijun Liu is a Hematologist and an Oncologist practicing medicine in Peoria, Illinois. Dr. Liu is highly rated in 105 conditions, according to our data. Her clinical expertise encompasses Severe Congenital Neutropenia, Lung Cancer, Pleuropulmonary Blastoma, Agranulocytosis, and Bone Marrow Aspiration. Dr. Liu is board certified in American Board Of Internal Medicine. Dr. Liu is currently accepting new patients.

Frequently Asked Questions about Dr. Madhuri Bajaj

How do I make an appointment with Dr. Madhuri Bajaj?

You can book an appointment with Dr. Madhuri Bajaj by calling their office at 309-243-3000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Madhuri Bajaj a top-rated expert for Familial Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Madhuri Bajaj is classified as an Distinguished expert for Familial Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Madhuri Bajaj specialize in?

While Dr. Madhuri Bajaj is a Hematology, they have specific expertise in Familial Colorectal Cancer, Colorectal Cancer, and Paget Disease of the Breast. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Madhuri Bajaj participate in research or clinical trials?

Yes. Dr. Madhuri Bajaj has published 9 articles and abstracts on conditions like Familial Colorectal Cancer. You can view a list of Dr. Madhuri Bajaj's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Madhuri Bajaj accept my insurance?

Dr. Madhuri Bajaj accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 309-243-3000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bajaj's expertise for a condition
ConditionClose
    View All 21 Distinguished Conditions
    View All 63 Advanced Conditions
    View All 118 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile